secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001104659-25-086011
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO appoints Todd Bazemore as permanent CEO; board election, updated compensation
--------------------------------------------------------------------------------

- Todd Bazemore appointed CEO effective Aug 29, 2025, replacing his interim CEO role; also elected Class II director.
- Annual base salary increased to $655,000; target annual bonus set at 60% of salary.
- Severance upon qualifying termination within 24 months of change of control: 24 months salary, 200% target bonus, plus benefits.
- Granted option to purchase 180,000 shares of common stock, vesting monthly over 4 years at close price on grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000110465925086011/0001104659-25-086011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000110465925086011/tm2524756d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-086011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer